Literature DB >> 9988272

Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse.

C D Vulpe1, Y M Kuo, T L Murphy, L Cowley, C Askwith, N Libina, J Gitschier, G J Anderson.   

Abstract

Iron is essential for many cellular functions; consequently, disturbances of iron homeostasis, leading to either iron deficiency or iron overload, can have significant clinical consequences. Despite the clinical prevalence of these disorders, the mechanism by which dietary iron is absorbed into the body is poorly understood. We have identified a key component in intestinal iron transport by study of the sex-linked anaemia (sla) mouse, which has a block in intestinal iron transport. Mice carrying the sla mutation develop moderate to severe microcytic hypochromic anaemia. Although these mice take up iron from the intestinal lumen into mature epithelial cells normally, the subsequent exit of iron into the circulation is diminished. As a result, iron accumulates in enterocytes and is lost during turnover of the intestinal epithelium. Biochemical studies have failed to identify the underlying difference between sla and normal mice, therefore, we used a genetic approach to identify the gene mutant in sla mice. We describe here a novel gene, Heph, encoding a transmembrane-bound ceruloplasmin homologue that is mutant in the sla mouse and highly expressed in intestine. We suggest that the hephaestin protein is a multicopper ferroxidase necessary for iron egress from intestinal enterocytes into the circulation and that it is an important link between copper and iron metabolism in mammals.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9988272     DOI: 10.1038/5979

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  229 in total

1.  Of metals, mice, and men: what animal models can teach us about body iron loading.

Authors:  G J Anderson; L W Powell
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

Review 2.  Hepcidin: a putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease.

Authors:  R E Fleming; W S Sly
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-17       Impact factor: 11.205

3.  Ferroportin mutation in autosomal dominant hemochromatosis: loss of function, gain in understanding.

Authors:  R E Fleming; W S Sly
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

4.  Mining copper transport genes.

Authors:  N C Andrews
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-05       Impact factor: 11.205

Review 5.  Molecular pathogenesis of iron overload.

Authors:  D Trinder; C Fox; G Vautier; J K Olynyk
Journal:  Gut       Date:  2002-08       Impact factor: 23.059

6.  Iron repletion relocalizes hephaestin to a proximal basolateral compartment in polarized MDCK and Caco2 cells.

Authors:  Seung-Min Lee; Zouhair K Attieh; Hee Sook Son; Huijun Chen; Mhenia Bacouri-Haidar; Chris D Vulpe
Journal:  Biochem Biophys Res Commun       Date:  2012-04-07       Impact factor: 3.575

7.  Immunoreactive hephaestin and ferroxidase activity are present in the cytosolic fraction of rat enterocytes.

Authors:  Perungavur N Ranganathan; Yan Lu; Brie K Fuqua; James F Collins
Journal:  Biometals       Date:  2012-02-17       Impact factor: 2.949

Review 8.  Animal models of age related macular degeneration.

Authors:  Mark E Pennesi; Martha Neuringer; Robert J Courtney
Journal:  Mol Aspects Med       Date:  2012-06-15

Review 9.  Iron homeostasis and the inflammatory response.

Authors:  Marianne Wessling-Resnick
Journal:  Annu Rev Nutr       Date:  2010-08-21       Impact factor: 11.848

10.  Genome-wide analysis of CDX2 binding in intestinal epithelial cells (Caco-2).

Authors:  Mette Boyd; Morten Hansen; Tine G K Jensen; Anna Perearnau; Anders K Olsen; Lotte L Bram; Mads Bak; Niels Tommerup; Jørgen Olsen; Jesper T Troelsen
Journal:  J Biol Chem       Date:  2010-06-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.